Latest Breaking News On - மருத்துவ சோதனை பதிவு - Page 2 : comparemela.com

A medical worker displays a vial of the Covaxin vaccine. | Indranil Mukherjee/AFP Bharat Biotech, the manufacturer of coronavirus vaccine Covaxin, on Wednesday criticised a recent study that found that its jab produced significantly fewer antibodies than Covishield. In a statement, the Hyderabad-based company claimed that the study “had lots of flaws”, ANI reported. The company also said that the phase 3 trial data for Covaxin will be made public in July. The indigenously developed vaccine was granted an emergency use authorisation in January – despite there being no phase 3 trial data. The company had then said it would submit efficacy results by March.

Andhra pradeshRaches ellaCentral drugs standard control organisationBharat biotechClinical trial registryCentral drugs standard controlBharat biotechCovaxin trial dataHarat biotech on covaxin antibodyOvaxin antibody newsBharat biotech newsCovaxin newsஆந்திரா பிரதேஷ்மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்பாரத் பயோடெக்மருத்துவ சோதனை பதிவு